INmune Bio
INMB
#10573
Rank
C$46.4 M
Marketcap
C$1.50
Share price
0.00%
Change (1 day)
-26.79%
Change (1 year)

Earnings for INmune Bio (INMB)

Earnings in 2026 (TTM): -C$25.55 Million

According to INmune Bio's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$65.58 Million a decrease over its 2024 earnings that were of -C$60.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for INmune Bio from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$25.55 Million-61.04%
2025 -C$65.58 Million9.15%
2024 -C$60.08 Million40.24%
2023 -C$42.85 Million9.92%
2022 -C$38.98 Million-10.02%
2021 -C$43.32 Million150.76%
2020 -C$17.28 Million57.58%
2019 -C$10.97 Million-38.28%
2018 -C$17.76 Million